A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab

BACKGROUND: The angiogenesis inhibitor monoclonal antibody Bevacizumab is presently the standard treatment for numerous neoplasms but particular toxicities are emerging, such as hypertension, haemorrhage, thromboembolism, gastrointestinal perforation, fistulae, and delayed wound healing. The additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tognarelli, Alessio, Faggioni, Lorenzo, Manassero, Francesca, Gadducci, Angiolo, Selli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902463/
https://www.ncbi.nlm.nih.gov/pubmed/31818277
http://dx.doi.org/10.1186/s12894-019-0566-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902463/
https://www.ncbi.nlm.nih.gov/pubmed/31818277
http://dx.doi.org/10.1186/s12894-019-0566-1

Ejemplares similares